Last reviewed · How we verify

Dexketoprofen/Vitamin B

Laboratorios Silanes S.A. de C.V. · Phase 3 active Small molecule

Dexketoprofen inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis and inflammation, while vitamin B provides nutritional support and may enhance analgesic efficacy.

Dexketoprofen inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis and inflammation, while vitamin B provides nutritional support and may enhance analgesic efficacy. Used for Acute and chronic pain conditions, Inflammatory conditions (arthritis, musculoskeletal pain).

At a glance

Generic nameDexketoprofen/Vitamin B
Also known asD/VitB
SponsorLaboratorios Silanes S.A. de C.V.
Drug classNSAID with vitamin supplement
TargetCOX-1, COX-2
ModalitySmall molecule
Therapeutic areaPain Management / Rheumatology
PhasePhase 3

Mechanism of action

Dexketoprofen is the active S-enantiomer of ketoprofen, a nonsteroidal anti-inflammatory drug (NSAID) that blocks COX-1 and COX-2 enzymes, thereby reducing pain, inflammation, and fever. The addition of vitamin B (likely B-complex vitamins) may support nerve function and potentially enhance the analgesic effect through nutritional supplementation, making this a combination product targeting pain management.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: